Briefly, A375 melanoma cells grown in light medium without serum were treated with Vemurafenib (BRAF inhibitor) and Trametinib (MEK1/2 inhibitor), while cells grown in heavy medium without serum were treated with vehicle. This evidence concerns the gene MAP2K1 and melanoma.